SCHEMBL2975710

SCHEMBL2975710

CC(C)(C)OC(=O)Cc1ccc(Oc2ccc(C(=O)Nc3ccc(Cl)c(Cl)c3)cc2)c(CNS(C)(=O)=O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
HPGD P15428 2/20 0.46
GAA P10253 1/20 0.46
PNLIP P16233 1/20 0.41
P2RX4 Q99571 1/20 0.40
SLC6A4 P31645 3/20 0.40
HTR2A P28223 2/20 0.40
KCNH2 Q12809 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A3 Q01959 1/20 0.40
PTGDR2 Q9Y5Y4 2/20 0.39
TRPV1 Q8NER1 1/20 0.39
STAT3 P40763 1/20 0.39
MAPT P10636 5/20 0.39
TP53 P04637 1/20 0.39
EPHX2 P34913 3/20 0.39
NR1H4 Q96RI1 2/20 0.39
NPC1 O15118 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2980029 0.89 KDM4E (0.50) LMNAMEN1KMT2AHPGDGAA
SCHEMBL2994879 0.84 KDM4E (0.58) LMNAMEN1KMT2AHPGDGAA
SCHEMBL2979319 0.83 KMT2A (0.48) KMT2ASLC6A4SLC6A2SLC6A3PTGDR2
SCHEMBL2975708 0.83 MEN1 (0.41) LMNAMEN1KMT2AHPGDGAA
SCHEMBL2991813 0.82 SLC6A4 (0.48) LMNAKMT2AHPGDSLC6A4SLC6A2
SCHEMBL2994986 0.82 KDM4E (0.47) LMNAMEN1KMT2ASLC6A4HTR2A
SCHEMBL2983993 0.82 PTGDR2 (0.50) LMNAMEN1KMT2AHPGDGAA
SCHEMBL2983991 0.82 PTGDR2 (0.50) LMNAMEN1KMT2AHPGDGAA
SCHEMBL2989727 0.81 PRMT1 (0.43) LMNAMEN1KMT2AHPGDGAA
SCHEMBL2985399 0.79 SMN1; SMN2 (0.46) LMNAMEN1KMT2ASLC6A4HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492437-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2013-07-23 US disclosed
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2012-08-09 US disclosed
US-8183289-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2012-05-22 US disclosed
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2010-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 LMNA 4646/4885MEN1 4149/4885KMT2A 505/4885
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 LMNA 4646/4885MEN1 4149/4885KMT2A 505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.